Measurement of the Metabolome in Melanoma Patients Using NMR Spectroscopy and Gas Chromatography.
Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY
Prospective, single-centre study with the central question of how the metabolome from blood samples, different body fluids and tissues between patients patients with malignant melanoma in different tumour tumour stages and healthy patients and whether this is suitable for early detection of initial diagnosis, recurrence or stage shift at an early stage. The biosamples are collected in the BioBank Dresden and used for the NMR and LC-MS analyses described here. It is planned to use the biosamples for further analyses.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Current or past history of melanoma
• Ongoing therapy or tumour aftercare at the Skin Cancer Centre at Dresden University Hospital
Locations
Other Locations
Germany
University Hospital Carl Gustav Carus
RECRUITING
Dresden
Contact Information
Primary
Frank Friedrich Gellrich, Dr. med.
frankfriedrich.gellrich@ukdd.de
+493514582497
Time Frame
Start Date: 2022-07-04
Estimated Completion Date: 2027-06
Participants
Target number of participants: 3000
Related Therapeutic Areas
Sponsors
Leads: Technische Universität Dresden
Collaborators: University Hospital Carl Gustav Carus